000 | 01656 a2200481 4500 | ||
---|---|---|---|
005 | 20250516095843.0 | ||
264 | 0 | _c20130507 | |
008 | 201305s 0 0 eng d | ||
022 | _a1873-264X | ||
024 | 7 |
_a10.1016/j.jpba.2012.05.034 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBianchi, F | |
245 | 0 | 0 |
_aDevelopment and validation of an high performance liquid chromatography-tandem mass spectrometry method for the determination of imatinib in rat tissues. _h[electronic resource] |
260 |
_bJournal of pharmaceutical and biomedical analysis _cJan 2013 |
||
300 |
_a103-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xanalysis |
650 | 0 | 4 |
_aBenzamides _xanalysis |
650 | 0 | 4 |
_aChromatography, High Pressure Liquid _xmethods |
650 | 0 | 4 |
_aDrug Monitoring _xmethods |
650 | 0 | 4 | _aImatinib Mesylate |
650 | 0 | 4 | _aLimit of Detection |
650 | 0 | 4 |
_aLiver _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMyocardium _xmetabolism |
650 | 0 | 4 |
_aPiperazines _xanalysis |
650 | 0 | 4 |
_aPyrimidines _xanalysis |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 | _aReference Standards |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 |
_aTandem Mass Spectrometry _xmethods |
650 | 0 | 4 | _aTissue Distribution |
700 | 1 | _aCaffarri, E | |
700 | 1 | _aCavalli, S | |
700 | 1 | _aLagrasta, C | |
700 | 1 | _aMusci, M | |
700 | 1 | _aQuaini, F | |
700 | 1 | _aSavi, M | |
773 | 0 |
_tJournal of pharmaceutical and biomedical analysis _gvol. 73 _gp. 103-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jpba.2012.05.034 _zAvailable from publisher's website |
999 |
_c21874469 _d21874469 |